Evofem Biosciences (EVFM) Misses Q4 EPS by 3c

Evofem Biosciences (OTC: EVFM) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $7.1 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.

You May Also Be Interested In

• BTIG Starts IQM Quantum Computers (IQMX) at Buy, PT $20
• Shree Cement Ltd (SRCM:IN) PT Lowered to INR20,726 at Investec
• Citi lowers East West Bancorp price target to $152